For: | Yusup A, Huji B, Fang C, Wang F, Dadihan T, Wang HJ, Upur H. Expression of trefoil factors and TWIST1 in colorectal cancer and their correlation with metastatic potential and prognosis. World J Gastroenterol 2017; 23(1): 110-120 [PMID: 28104986 DOI: 10.3748/wjg.v23.i1.110] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v23/i1/110.htm |
Number | Citing Articles |
1 |
Aikeremu Yusufu, Paerhati Shayimu, Rousidan Tuerdi, Cheng Fang, Fei Wang, Haijiang Wang. TFF3 and TFF1 expression levels are elevated in colorectal cancer and promote the malignant behavior of colon cancer by activating the EMT process. International Journal of Oncology 2019; doi: 10.3892/ijo.2019.4854
|
2 |
Feifei Cheng, Xuejuan Wang, Yi-Shiou Chiou, Chuyu He, Hui Guo, Yan Qin Tan, Basappa Basappa, Tao Zhu, Vijay Pandey, Peter E. Lobie. Trefoil factor 3 promotes pancreatic carcinoma progression via WNT pathway activation mediated by enhanced WNT ligand expression. Cell Death & Disease 2022; 13(3) doi: 10.1038/s41419-022-04700-4
|
3 |
Ramin Shekarriz, Nafiseh Kochaki, Mohammad Eslami-Jouibari, Versa Omrani-Nava, Mohadeseh Ahmadi, Reza Alizadeh-Navaei. TFF1 gene single nucleotide polymorphism (rs3761376) and colorectal cancer risk. Molecular Biology Reports 2022; 49(10): 10127 doi: 10.1007/s11033-022-07828-w
|
4 |
Yunjia Yang, Minda Zhang, Chenyu Jin, Yang Ding, Mengdi Yang, Rui Wang, Yunjiang Zhou, Yang Zhou, Tao Li, Keke Wang, Rong Hu. Absent in melanoma 2 suppresses epithelial‐mesenchymal transition via Akt and inflammasome pathways in human colorectal cancer cells. Journal of Cellular Biochemistry 2019; 120(10): 17744 doi: 10.1002/jcb.29040
|
5 |
Eva Parisi, Anabel Sorolla, Robert Montal, Rita González-Resina, Anna Novell, Antonieta Salud, Maria Sorolla. Prognostic Factors Involved in the Epithelial–Mesenchymal Transition Process in Colorectal Cancer Have a Preponderant Role in Oxidative Stress: A Systematic Review and Meta-Analysis. Cancers 2020; 12(11): 3330 doi: 10.3390/cancers12113330
|
6 |
Satoru Sasagawa, Jun Kumai, Toru Wakamatsu, Yoshihiro Yui. Improvement of histone deacetylase inhibitor efficacy by SN38 through TWIST1 suppression in synovial sarcoma. Cancer Innovation 2024; 3(2) doi: 10.1002/cai2.113
|
7 |
A. Lafuente-Sanchis, A. Olmo, J. Carretero, J. Alcacer Fernandez-Coronado, M. Estors-Guerrero, N. J. Martínez-Hernández, A. Cremades, A. Zúñiga, J. Alcacer, R. Farras, M. Cuenca, J. M. Galbis-Caravajal. Clinical significance of epithelial–mesenchymal transition-related markers expression in the micrometastatic sentinel lymph node of NSCLC. Clinical and Translational Oncology 2020; 22(3): 381 doi: 10.1007/s12094-019-02138-3
|
8 |
Jeng-Wei Lu, Yuxi Sun, Liang-In Lin, Dong Liu, Zhiyuan Gong. Exacerbation of Liver Tumor Metastasis in twist1a+/xmrk+ Double Transgenic Zebrafish following Lipopolysaccharide or Dextran Sulphate Sodium Exposure. Pharmaceuticals 2021; 14(9): 867 doi: 10.3390/ph14090867
|
9 |
Bo Zhu, Yichao Wang, Xiaolin Wang, Shiwu Wu, Lei Zhou, Xiaomeng Gong, Wenqing Song, Danna Wang. Evaluation of the correlation of MACC1, CD44, Twist1, and KiSS-1 in the metastasis and prognosis for colon carcinoma. Diagnostic Pathology 2018; 13(1) doi: 10.1186/s13000-018-0722-z
|
10 |
Hyunwoo Kim, Sungmin Lee, Eunguk Shin, Ki Moon Seong, Young Woo Jin, HyeSook Youn, BuHyun Youn. The Emerging Roles of Exosomes as EMT Regulators in Cancer. Cells 2020; 9(4): 861 doi: 10.3390/cells9040861
|
11 |
Yinghao Jiang, Guangming Liu, Wei Ye, Jianjin Xie, Chunfa Shao, Xiaowei Wang, Xia Li. ZEB2-AS1 Accelerates Epithelial/Mesenchymal Transition Through miR-1205/CRKL Pathway in Colorectal Cancer. Cancer Biotherapy and Radiopharmaceuticals 2020; 35(2): 153 doi: 10.1089/cbr.2019.3000
|
12 |
Fahimeh Fattahi, Leili Saeednejad Zanjani, Somayeh Vafaei, Zohreh Habibi Shams, Jafar Kiani, Marzieh Naseri, Elmira Gheytanchi, Zahra Madjd. Expressions of TWIST1 and CD105 markers in colorectal cancer patients and their association with metastatic potential and prognosis. Diagnostic Pathology 2021; 16(1) doi: 10.1186/s13000-021-01088-1
|
13 |
Elena A. Pudova, Anna V. Kudryavtseva, Maria S. Fedorova, Andrew R. Zaretsky, Dmitry S. Shcherbo, Elena N. Lukyanova, Anatoly Y. Popov, Asiya F. Sadritdinova, Ivan S. Abramov, Sergey L. Kharitonov, George S. Krasnov, Kseniya M. Klimina, Nadezhda V. Koroban, Nadezhda N. Volchenko, Kirill M. Nyushko, Nataliya V. Melnikova, Maria A. Chernichenko, Dmitry V. Sidorov, Boris Y. Alekseev, Marina V. Kiseleva, Andrey D. Kaprin, Alexey A. Dmitriev, Anastasiya V. Snezhkina. HK3 overexpression associated with epithelial-mesenchymal transition in colorectal cancer. BMC Genomics 2018; 19(S3) doi: 10.1186/s12864-018-4477-4
|
14 |
Zu‑Cheng Xie, Jia‑Cheng Huang, Li‑Jie Zhang, Bin‑Liang Gan, Dong‑Yue Wen, Gang Chen, Sheng‑Hua Li, Hai‑Biao Yan. Exploration of the diagnostic value and molecular mechanism of miR‑1 in prostate cancer: A study based on meta‑analyses and bioinformatics. Molecular Medicine Reports 2018; doi: 10.3892/mmr.2018.9598
|
15 |
Kevin D. Seely, Amanda D. Morgan, Lauren D. Hagenstein, Garrett M. Florey, James M. Small. Bacterial Involvement in Progression and Metastasis of Colorectal Neoplasia. Cancers 2022; 14(4): 1019 doi: 10.3390/cancers14041019
|
16 |
Sinem DURMUŞ, Berrin PAPİLA KUNDAKTEPE, Remise GELİŞGEN, Çiğdem PAPİLA, Hafize UZUN. EXPLORING THE ROLE OF sFRP-4, TFF-3, NF-кB AND ROMO1 LEVELS IN COLORECTAL CANCER: IMPLICATIONS FOR PATHOPHYSIOLOGY AND DISEASE PROGRESSION. Acta Medica Nicomedia 2024; 7(1): 120 doi: 10.53446/actamednicomedia.1391225
|
17 |
Samar M. Abdel Raouf, Taiseer R. Ibrahim, Lobna A. Abdelaziz, Mohamed I. Farid, Salem Y Mohamed. Prognostic Value of TWIST1 and EZH2 Expression in Colon Cancer. Journal of Gastrointestinal Cancer 2021; 52(1): 90 doi: 10.1007/s12029-019-00344-4
|
18 |
RamaRao Malla, Priyamvada Bhamidipati.
Isoquinoline Alkaloids: Promising Natural Compounds for Targeting Angiogenesis and Metastasis in Colon Cancer
. Onco Therapeutics 2022; 9(2): 13 doi: 10.1615/OncoTherap.2022045086
|
19 |
Hang Du, Jingling Tang, Xiaoyun Li, Xinjun Wang, Liyun Wu, Ruyi Zhang, Pingsheng Hu, Yuan Yang. Siglec-15 Is an Immune Suppressor and Potential Target for Immunotherapy in the Pre-Metastatic Lymph Node of Colorectal Cancer. Frontiers in Cell and Developmental Biology 2021; 9 doi: 10.3389/fcell.2021.691937
|
20 |
Maria S. Fedorova, Anastasiya V. Snezhkina, Elena A. Pudova, Ivan S. Abramov, Anastasiya V. Lipatova, Sergey L. Kharitonov, Asiya F. Sadritdinova, Kirill M. Nyushko, Kseniya M. Klimina, Mikhail M. Belyakov, Elena N. Slavnova, Nataliya V. Melnikova, Maria A. Chernichenko, Dmitry V. Sidorov, Marina V. Kiseleva, Andrey D. Kaprin, Boris Y. Alekseev, Alexey A. Dmitriev, Anna V. Kudryavtseva. Upregulation of NETO2 gene in colorectal cancer. BMC Genetics 2017; 18(S1) doi: 10.1186/s12863-017-0581-8
|
21 |
Abdulaziz Alfahed. Deregulation of TWIST1 expression by promoter methylation in gastrointestinal cancers. Saudi Journal of Biological Sciences 2024; 31(8): 103842 doi: 10.1016/j.sjbs.2023.103842
|